Browse Reports

Wayfair Inc. is an omni-channel retailer focused on home goods, providing customers with a visually inspired and compelling online shopping experience. The company offers a broad selection of over 40 million products from approximately 20,000 suppliers, spanning furniture, décor, housewares, and home improvement categories. Its customer base includes a wide range of demographics and businesses. Wayfair operates multiple brands, including Wayfair, AllModern, Birch Lane, Joss & Main, Perigold, and Wayfair Professional, each targeting different customer segments. The Wayfair brand accounts for the majority of net revenue and international operations. The company complements its e-commerce platform with a growing physical retail presence, operating 12 stores across four U.S. states as of the end of 2025. Wayfair emphasizes superior customer service, a proprietary logistics network, and technology investments, including AI, to enhance the shopping and fulfillment experience. The company faces competition from various retail segments and online marketplaces and manages risks related to macroeconomic conditions and supply chain challenges [S1][S2].

Ardelyx, Inc. is a biopharmaceutical company that develops and commercializes innovative medicines targeting significant unmet medical needs. Its core commercial products are based on tenapanor, a first-in-class, minimally absorbed NHE3 inhibitor. The company markets IBSRELA® for adults with irritable bowel syndrome with constipation (IBS-C) and XPHOZAH® for reducing serum phosphorus in adults with chronic kidney disease (CKD) on dialysis who have inadequate response or intolerance to phosphate binders. Ardelyx is conducting a Phase 3 clinical trial (ACCEL) to evaluate tenapanor for chronic idiopathic constipation (CIC) and is developing a next-generation NHE3 inhibitor, RDX10531. The company has established commercial organizations with specialty sales forces and patient support programs. It has collaboration agreements for tenapanor commercialization in Canada, Japan, and China. Ardelyx has incurred losses since inception and funds operations through product sales, equity offerings, loans, and partnerships. The company reported $31.2 million in cash and cash equivalents and a net loss of $37.6 million for Q1 2026 [S1][S2].

Syndax Pharmaceuticals Inc is a biopharmaceutical company advancing innovative cancer therapies. It currently markets two approved products, Revuforj (revumenib) and Niktimvo (axatilimab-csfr), and has a robust pipeline of clinical development programs. The company operates in a single segment from its base in New York, NY. Syndax generates revenue primarily from product sales and collaboration agreements. The company is subject to risks common in the pharmaceutical industry, including regulatory approval, clinical trial success, supply chain reliability, intellectual property protection, and compliance with regulatory requirements. Syndax maintains strong liquidity with significant cash, short-term investments, and a current ratio above 5 as of the latest quarter ending March 31, 2026.

CNH Industrial N.V. is a Netherlands-incorporated company with principal offices in the UK, operating globally in the agriculture and construction equipment sectors, as well as financial services related to its products. The company manages three reportable segments: Agriculture, Construction, and Financial Services. Its operations span North America, EMEA, South America, and Asia Pacific. The Agriculture and Construction segments are collectively referred to as Industrial Activities. CNH monitors its financial performance using both GAAP and non-GAAP measures, including Adjusted EBIT and Net Cash (Debt). The company faces cyclical industry conditions, particularly in agricultural equipment demand, influenced by macroeconomic factors such as tariffs, input costs, and geopolitical events. Management emphasizes operational discipline and investment in technology to navigate these conditions.

DIEBOLD NIXDORF, Inc is a publicly traded company listed on the New York Stock Exchange under the ticker DBD. The company provides quarterly and annual financial disclosures, with the latest filings dated early 2026. As of the first quarter of 2026, the company reported revenues near $892 million and net income of $5 million. Liquidity metrics indicate a current ratio of 1.28 and a cash ratio of 0.26, reflecting its short-term financial position. Leadership changes include the appointment of a new principal accounting officer in early 2026. Recent public coverage focuses on earnings results, stock price movements, and investor interest.

United States Lime & Minerals Inc manufactures and supplies lime and limestone products primarily to the construction, industrial, environmental, metals, roof shingle, agriculture, and oil and gas services sectors. The company operates plants and distribution facilities in Arkansas, Colorado, Louisiana, Missouri, Oklahoma, and Texas through wholly owned subsidiaries. It also holds royalty and non-operated working interests in natural gas wells in Texas. The company manages its operations as a single reportable segment focused on lime and limestone products. Revenue recognition occurs upon shipment, and trade receivables are generally short-term and unsecured with an allowance for credit losses. The company maintains a revolving credit facility and has a strong liquidity position as of March 31, 2026.

Trupanion, Inc. provides medical insurance for cats and dogs in the United States, Canada, and certain countries in Continental Europe. The company operates two main segments: a subscription business generating revenue primarily from insurance premiums paid by pet owners, and an other business segment that underwrites policies on behalf of third parties, including Pets Best Insurance Services. The subscription business is designed to offer high-value, data-driven insurance products priced according to each pet's unique characteristics, such as breed, age, and geography. Trupanion's proprietary software enables direct payment to veterinary hospitals, enhancing the member experience by reducing payment friction. The company leverages a network of Territory Partners who cultivate relationships with veterinarians to drive member acquisition and retention. Trupanion's subscription business has demonstrated significant growth in enrolled pets and revenue over the past decade. The company also pursues complementary non-insurance offerings and continues to expand its product portfolio and distribution channels [S1][S2].

ADT Inc. operates as a leading provider of security, interactive, and smart home solutions primarily serving residential and small business customers across the United States. The company’s business model centers on delivering safety and connectivity through a combination of professional and self-installation offerings, integrated via its proprietary ADT+ platform. This platform-centric approach combines software-as-a-product with human expertise and ambient sensing technologies to provide real-time, personalized security solutions. ADT generates revenue mainly from recurring monthly fees for monitoring services and from security installation and product sales. The company tracks key performance indicators such as recurring monthly revenue (RMR), gross customer revenue attrition, adjusted earnings per share (EPS), and adjusted EBITDA to evaluate operational performance. As of the end of 2025, ADT served approximately 6.1 million subscribers and reported total revenue exceeding $5 billion. The company manages a significant debt load and maintains liquidity through cash, credit facilities, and cash flows from operations. ADT also engages in share repurchases and pays dividends to shareholders. The company faces operational risks including customer attrition, competitive pressures, macroeconomic influences, supply chain challenges, and legal proceedings typical of its industry.

NWPX Infrastructure, Inc., formerly Northwest Pipe Company, manufactures water infrastructure products including steel pipe and precast concrete systems. The Water Transmission Systems segment produces engineered steel pipes and fittings, while the Precast segment offers wastewater, stormwater, and water management products with integrated OEM components. The company serves installation contractors bidding to public agencies and private water companies. It operates 13 manufacturing facilities across North America and holds patents on proprietary technologies such as the Permalok® Radial Bending Joint and InfraShield® Joint System. Quality certifications include ISO multi-site registration, NSF cement lining certification, and UL 508A for control panels. NWPX emphasizes product quality, competitive pricing, and customer service. The company faces risks including cybersecurity threats, supply chain challenges, and regulatory compliance.

Spok Holdings, Inc offers a focused suite of unified clinical communication and collaboration solutions, including call center applications, clinical alerting and notifications, wireless messaging services, mobile communications, and public safety solutions. The company primarily targets the healthcare industry, especially hospitals, but also serves government agencies, public safety institutions, educational institutions, hospitality, and manufacturing sectors. Spok's revenue streams are divided into wireless messaging services and software solutions, with software licenses granted under standard agreements. The company operates as a single segment and primarily generates revenue in the United States. It maintains a network of approximately 2,869 active transmitters across the U.S. and leases facility space in multiple states. Spok's financials show consistent revenue generation with recent quarterly declines, ongoing dividend payments, and a share repurchase program authorized but not recently utilized. The company is undertaking a strategic realignment to improve cost efficiency.

Northern Trust Corporation is a financial services firm with diversified operations including wealth management, asset servicing, investment management, securities lending, and other trust-related services. The company’s 2025 annual report and Q1 2026 quarterly report provide detailed financial and operational disclosures. Northern Trust serves institutional and individual clients, managing assets and providing fiduciary and banking services.

Tenet Healthcare Corporation is a large, diversified healthcare services company headquartered in Dallas, Texas, with a Global Business Center in the Philippines. The company operates through two primary segments: Hospital Operations and Ambulatory Care. The Hospital Operations segment includes 50 acute care and specialty hospitals, a network of employed physicians, and 132 outpatient facilities such as urgent care centers and imaging centers. The Ambulatory Care segment, operated through USPI Holding Company, includes ownership interests in 533 ambulatory surgery centers and 26 surgical hospitals across 37 states. Tenet also provides revenue cycle management and value-based care services through Conifer Health Solutions, which it fully owns as of January 2026. The company employs approximately 99,000 people and operates in a complex regulatory environment. Financially, Tenet reported strong liquidity and earnings metrics as of Q1 2026.

Apollo Commercial Real Estate Finance, Inc. is a Maryland corporation and a REIT that primarily originates, acquires, invests in, and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. The company is externally managed by a subsidiary of Apollo Global Management, leveraging Apollo's global platform and expertise. ARI sold its commercial real estate loan portfolio to Athene for approximately $8.6 billion. The company maintains a leveraged capital structure and actively manages its portfolio with a dedicated asset management team. ARI adheres to investment guidelines designed to maintain REIT qualification and limit concentration risk. The company generates income primarily from interest on its loan portfolio and related real estate owned operations.

Air Lease Corp operates in the aircraft leasing industry, managing a capital-intensive business model with a focus on leasing commercial aircraft to airline customers globally. The company completed a significant merger in April 2026, becoming an indirect subsidiary of Sumisho Air Lease Corporation, jointly owned by Sumitomo Corporation, SMBC Aviation Capital, Apollo managed funds, and Brookfield. The merger resulted in changes to the board of directors and executive leadership, with Noriyuki Hiruta appointed as CEO. The company’s business involves acquiring, leasing, and managing aircraft fleets, including recent deliveries of Boeing 737-8 aircraft to customers such as Air Canada. The company reported FY 2025 revenues of approximately $3.02 billion and net income of approximately $1.09 billion. The company’s stock was delisted from the NYSE following the merger. The company announced a workforce reduction plan post-merger affecting 40% of employees, with severance and benefits provided. Executive compensation is structured around pay-for-performance principles tied to financial and operational metrics. The company faces typical risks related to merger completion, regulatory approvals, and integration.

Talkspace, Inc. operates in the mental health services sector, offering innovative and personalized care solutions. The company has a management team led by CEO Jon Cohen and CFO Ian Harris. Talkspace has pursued growth through acquisitions, including Wisdo Health, and marketing campaigns aimed at increasing user engagement. The company reported revenues of $27.6 million for fiscal year 2024 and net income of $7.793 million for fiscal year 2025. In March 2026, Talkspace entered into a merger agreement to be acquired by Universal Health Services, Inc., subject to stockholder and regulatory approvals. The merger is expected to result in the company becoming a wholly owned subsidiary of Universal Health Services and delisting from Nasdaq.

NEXGEL, INC. operates in the regenerative biomaterials sector, focusing on commercial-stage and development-stage biomaterial products. The company completed an asset purchase and exclusive license agreement with Celularity, Inc. in early 2026, acquiring rights to six biomaterial products and related assets. The transaction includes upfront and milestone payments, with an amended total consideration of $13.3 million. NEXGEL has a convertible note facility providing capital with secured interests in company assets. The company reported significant revenue growth in 2024 and early 2025, reflecting expansion in its product offerings and partnerships, including with STADA Arzneimittel AG. The company is publicly traded on Nasdaq under the ticker NXGL but has received a deficiency notice due to its stock price falling below the minimum bid price requirement. Management changes include the appointment of Ian Blackman as CFO in April 2026. Financially, the company reported a net loss for 2025 but maintains liquidity with a current ratio of 1.47 as of year-end 2025.

Cambium Networks Corp is a global provider of wireless broadband networking infrastructure products and services, operating primarily through its subsidiary Cambium Networks, Ltd. The company employs approximately 486 full-time employees worldwide, with a significant portion located outside the United States. It outsources manufacturing to third-party manufacturers predominantly outside the U.S., relying on distribution hubs in the U.S., Netherlands, and Vietnam to fulfill worldwide sales. Sales are primarily conducted through distributors and value-added resellers, with a concentration of revenues from a few key distributors. The company faces operational challenges including supply chain disruptions, component shortages, and quality control issues. Cambium Networks has experienced fluctuations in operating results due to the timing and size of sales orders and seasonal demand variations. The company has been delisted from Nasdaq and now trades on the OTC Expert Market, resulting in reduced liquidity and market visibility. Financially, the company reported a net loss and negative earnings per share for the fiscal year ended December 31, 2025, with liquidity constraints reflected in a current ratio below 1.0. The company is engaged in cost reduction efforts and working with lenders to address defaults under its secured Credit Agreement. It also faces risks related to intellectual property claims, cybersecurity, regulatory compliance, and international operations.

Cambium Networks Corp is a global provider of wireless broadband solutions, operating through its subsidiary Cambium Networks, Ltd. The company designs and sells wireless networking products primarily through distributors and channel partners worldwide, with significant international revenue exposure. Manufacturing is outsourced to third-party manufacturers mainly located outside the US, including Vietnam and Thailand. The company emphasizes innovation and integrity in its corporate culture and maintains a global workforce of approximately 486 employees as of end 2025. Cambium Networks faces operational risks related to supply chain dependencies, distributor concentration, and long sales cycles. Financially, the company reported a net loss and negative earnings per share for fiscal 2025, with liquidity challenges and noncompliance with credit covenants leading to delisting from Nasdaq and trading on OTC markets [S1].

Cambium Networks Corp, through its subsidiary Cambium Networks, Ltd., designs and sells wireless broadband networking infrastructure products and services globally. The company operates with a workforce of approximately 486 employees across 25 countries, with significant international operations and sales. Manufacturing is outsourced to third-party providers primarily located outside the U.S., including countries such as Vietnam and Thailand, which exposes the company to risks related to tariffs, trade regulations, and supply chain disruptions. Cambium Networks relies heavily on a limited number of distributors for sales, which impacts demand visibility and revenue predictability. The company has faced challenges including product shipment delays, quality control issues, and component shortages. Financially, Cambium Networks reported a net loss and liquidity constraints as of the fiscal year ended December 31, 2025. The company was delisted from Nasdaq in March 2026 and currently trades on the OTC Expert Market, which has reduced liquidity and market visibility. Cambium Networks is undertaking cost reduction initiatives and working with lenders to address defaults under its Credit Agreement, which matures in late 2026. The company emphasizes innovation, ethical business practices, and employee development as core to its culture.

iRhythm Holdings, Inc. designs, develops, and commercializes device-based technology for ambulatory cardiac monitoring (ACM) services. Its core product offerings combine a wire-free, patch-based, 14-day wearable biosensor with proprietary cloud-based analytic software to continuously record and analyze electrocardiogram (ECG) data. The company provides long-term continuous monitoring (LTCM) and mobile cardiac telemetry (MCT) services primarily for patients suspected of having infrequent or asymptomatic arrhythmias. iRhythm operates Medicare-enrolled independent diagnostic testing facilities (IDTFs) staffed with qualified technicians who validate data and notify physicians of clinically actionable arrhythmias. The company has delivered over twelve million patient reports and holds approximately 40% penetration of the U.S. ambulatory cardiac monitoring market. It targets cardiology, electrophysiology, primary care, and other specialties, focusing on integrated delivery networks and risk-bearing entities. iRhythm has expanded its presence internationally through direct sales and distributor relationships in the UK, Europe, and Japan. The company emphasizes physician education, clinical evidence publication, and electronic health record (EHR) integration to support adoption and clinical workflow integration. Its proprietary FDA-cleared deep learning algorithms analyze ECG data, with reports accessible via the ZioSuite portal and mobile apps. The company reported a net loss of $13.9 million for Q1 2026 and maintains strong liquidity with a current ratio of 5.17 as of March 31, 2026.

DexCom, Inc. develops and commercializes continuous glucose monitoring (CGM) systems designed to help patients, caregivers, and clinicians manage diabetes and metabolic health. The company markets its products globally through a combination of direct sales and distribution partnerships. Its product portfolio includes the Dexcom G7 CGM system and the Stelo biosensor, the latter targeting adults with prediabetes and Type 2 diabetes who do not use insulin. DexCom generates revenue primarily from disposable sensors and reusable hardware components. The company invests in research and development to enhance its sensing technology and expand applications beyond glucose monitoring, including metabolic health insights and other patient populations.

FiEE, Inc. is a digital service provider that completed a business transformation in 2025, moving away from its legacy networking hardware business. Its current operations focus on integrating artificial intelligence and data analytics into digital content services, software development, and digital authentication. The company ceased its legacy operations by the end of 2025 and launched its new business model, generating $6.2 million in service fees and achieving profitability in that year. FiEE pursues growth through acquisitions, including a recent majority equity investment and convertible loan in a Chinese cultural company. The company operates in a competitive and rapidly evolving market with significant regulatory and operational risks.

FibroBiologics, Inc. is a Delaware-based biotechnology company focused on developing fibroblast-based cell therapy products. The company operates primarily through research and development of its product candidates, which are manufactured via third-party contract development and manufacturing organizations (CDMOs). FibroBiologics has encountered manufacturing challenges, including process issues and low yields, which have impacted clinical trial timelines, particularly for its CYWC628 candidate targeting diabetic foot ulcers. The company reported a net loss and negative cash flows, with liquidity supported by recent equity offerings and cost reduction initiatives. FibroBiologics maintains a board of directors with experienced leadership, including its founder and CEO Pete O'Heeron. The company has recently secured new patents and actively participates in industry conferences. It is listed on the Nasdaq Capital Market and has addressed prior listing compliance issues.

Prologis, Inc. operates as a self-managed REIT specializing in logistics real estate, with a global footprint spanning 20 countries and four continents. The company’s portfolio includes approximately 1.3 billion square feet of logistics and data center properties, managed both on a wholly owned and co-investment basis. Prologis’s business is organized into two segments: Real Estate, which includes rental operations and development of logistics and data center facilities, and Strategic Capital, which involves partnerships with institutional investors through co-investment ventures. The Real Estate segment generates the majority of revenues through long-term leases with fixed or inflation-linked escalations, serving a broad and diversified customer base including major logistics and retail companies. Development activities focus on modern, sustainable facilities and selective data center projects, leveraging strategic locations and access to power. The Strategic Capital segment provides asset and property management services and generates management fees and promote revenues, primarily outside the U.S. Prologis emphasizes sustainability through solar energy projects and ESG integration. The company maintains a strong balance sheet with conservative leverage, significant liquidity, and a long average debt maturity profile. Foreign currency and interest rate risks are actively managed through hedging and borrowing strategies. Recent developments include a dividend increase and a focus on data center growth.

Cullen/Frost Bankers, Inc. operates as a financial holding company headquartered in San Antonio, Texas, serving primarily Texas markets. Its business includes commercial and consumer banking, trust and investment management, insurance, brokerage, mutual funds, leasing, treasury management, capital markets advisory, and item processing. The company manages a diversified loan portfolio and maintains liquidity through a mix of liquid assets and access to wholesale funding. It actively manages capital through stock repurchase programs and pays dividends on common and preferred stock. Governance structures include dedicated cybersecurity oversight committees reporting to the board. The company regularly discloses financial results and risk factors in SEC filings.

Cable One, Inc. is a broadband services provider operating primarily through its subsidiary MBI, which offers broadband, fiber connectivity, video, and voice services to residential and commercial customers under the Vyve Broadband brand. The company currently owns approximately 45% of MBI and has entered into a definitive agreement to acquire the remaining 55%, subject to regulatory approvals and customary closing conditions. The acquisition involves a purchase price based on MBI's adjusted EBITDA and net indebtedness, with financing planned through cash and debt facilities. Cable One reported solid liquidity metrics as of March 31, 2026, including $165.6 million in cash and a current ratio of 1.75. The company reported net income of $35.8 million and basic EPS of $6.29 for Q1 2026. Recent news and filings highlight leadership changes, including a new CEO and independent chair, and a merger involving Clearwave Fiber LLC, a joint venture in which Cable One holds an interest. The company faces risks typical of the sector, including competition, technology evolution, regulatory approvals, integration of acquisitions, and cybersecurity threats.

Coursera, Inc. is a Delaware public benefit corporation and Certified B Corporation that provides an online learning platform connecting learners, content creators, and enterprise customers. The platform offers a broad portfolio of educational content, including open online courses, certificates, and degree programs developed in collaboration with academic institutions and other content creators. Revenue is generated through subscriptions, content fees, and tuition shares. The company serves both individual learners and enterprise customers globally, with a focus on expanding offerings, scaling technology, and growing its learner and customer base. Coursera faces a competitive and rapidly evolving market landscape, including emerging AI technologies and new entrants. The company is currently pursuing a merger with Udemy, which involves customary regulatory and execution risks. Coursera's financials reflect ongoing investments in growth and platform development, with net losses continuing in recent periods. The company maintains a strong liquidity position as of Q1 2026.

OneSpan Inc. is a Delaware-incorporated company headquartered in Boston, Massachusetts, publicly traded on NASDAQ under the ticker OSPN. The company operates in the digital identity and anti-fraud solutions sector, providing products and services to its customers. As of the quarter ended March 31, 2026, OneSpan reported $49.75 million in cash and cash equivalents and $122.88 million in current assets against $98.00 million in current liabilities, resulting in a current ratio of 1.25 and a cash ratio of 1.53, indicating a solid liquidity position. The company reported net income of $11.57 million for Q1 2026 with basic and diluted earnings per share of $0.31 and $0.30 respectively. OneSpan has a $100 million revolving credit facility established in June 2025 with MUFG Bank, maturing in 2030, with no borrowings outstanding as of that date. The company regularly communicates financial results and operational updates through earnings call transcripts and press releases, with recent coverage spanning from Q3 2024 through Q1 2026.

Royal Caribbean Cruises Ltd. is a leading global cruise vacation company operating three main brands—Royal Caribbean, Celebrity Cruises, and Silversea—plus a 50% interest in TUI Cruises. The company offers a broad range of cruise vacations targeting multiple market segments from contemporary family to ultra-luxury and expedition travel. Its fleet includes 69 ships with plans for new ship deliveries and expansion of private destinations. The company emphasizes innovation, technology integration, environmental sustainability, and customer engagement to enhance its competitive position in the global vacation industry. It competes with other major cruise lines and land-based vacation alternatives. The company maintains a focus on cost efficiency, capital allocation, and liquidity management while investing in fleet upgrades and new vessels.

ASGN Inc is a technology and digital engineering company providing IT solutions to commercial and government clients primarily in the United States. The company operates under two segments: Commercial and Federal Government. The Commercial Segment serves Fortune 1000 and large mid-market clients across six solution areas and five industries, offering consulting, creative digital marketing, and permanent placement services. The Federal Government Segment delivers advanced IT solutions in data and AI, cybersecurity, software engineering, and enterprise platforms to defense, intelligence, national security, and other federal agencies. ASGN has a broad talent pool of approximately 19,600 billable professionals and 2,800 internal employees. The company leverages proprietary assets, accelerators, and strategic partnerships with leading technology providers to deliver tailored IT solutions. ASGN's business model emphasizes higher-value consulting services with enhanced margin opportunities and a unique delivery model that provides cost advantages and flexibility. The company maintains a significant contract backlog and a diversified client base, with no single client other than the U.S. federal government representing more than 10% of revenues.

Cerus Corporation is a medical technology company specializing in blood safety products. The company’s business model centers on developing and commercializing technologies that reduce the risk of transfusion-transmitted infections. Cerus generates revenue primarily through product sales, with recent disclosures indicating growth in product revenue. The company maintains liquidity with a current ratio above 1.6 and cash reserves exceeding $27 million as of Q1 2026. Executive leadership changes and compensation structures have been recently updated, reflecting governance and retention strategies. No legal proceedings are currently reported.

Summit Therapeutics Inc. is a biopharmaceutical company specializing in oncology drug development. Its lead candidate, ivonescimab, is a bispecific antibody designed to block PD-1 and VEGF pathways simultaneously, potentially enhancing antitumor activity. The company has licensed global rights to ivonescimab from Akeso, covering the US, Canada, Europe, Japan, Latin America, Middle East, and Africa. Summit is conducting multiple Phase III clinical trials targeting various NSCLC patient populations and colorectal cancer. The HARMONi trial showed significant progression-free survival benefits and positive overall survival trends, supporting the FDA's acceptance of the BLA. Summit's operations focus on clinical development, regulatory submissions, and preparing for potential commercialization. The company has incurred significant losses and depends on external funding to sustain operations. Manufacturing is outsourced, primarily to Akeso, with associated operational risks.

RIOT PLATFORMS INC operates within the Financial Services sector, specifically in Capital Markets. The company reported $167.2 million in revenue for Q1 2026 but incurred a net loss of $500.5 million during the same period. As of March 31, 2026, it held $205.7 million in cash and equivalents and maintained a current ratio of 1.08, indicating modest liquidity. The company has engaged in stock repurchases and secured a $200 million credit facility with Coinbase Credit, Inc. Recent developments highlight its focus on AI data center infrastructure and strategic growth initiatives.

Rivian is an American automotive technology company that designs, manufactures, and sells electric vehicles and related software and services. Its consumer vehicle lineup includes the R1T pickup and R1S SUV, with plans to expand into midsize vehicles such as the R2 SUV and R3 crossover. The company also produces commercial electric delivery vans in partnership with Amazon, which has placed a large order. Rivian's vehicles incorporate proprietary technologies including a zonal network electrical architecture, an AI-driven autonomy platform, and cloud-enabled over-the-air software updates. The company sells vehicles directly to consumers and commercial customers in the U.S. and is expanding its charging infrastructure. Rivian operates in a highly competitive market with established automakers and faces challenges related to production scaling, supply chain, regulatory environment, and capital requirements.

TruGolf Holdings, Inc. is a virtual golf technology company headquartered in Utah, USA. It develops and markets golf simulation products and services, including hardware and software solutions. The company is led by CEO Christopher Jones, who has a background in video game development and has been with the company since its inception. TruGolf's product portfolio includes the portable LaunchBox launch monitor and AI-enhanced golf coaching technologies. The company is expanding its franchising operations with new locations and franchisees. Financial disclosures indicate revenues of approximately $4.11 million for the first nine months of 2025 and a net loss of about $15.23 million for the full year 2025. Liquidity ratios as of December 31, 2025, show a current ratio of 1.07 and a cash ratio of 0.9, reflecting near parity between current assets and liabilities.

Expion360 Inc. operates in the energy storage sector, focusing on home energy storage solutions. The company is publicly traded on The Nasdaq Capital Market under the ticker XPON and is classified as an emerging growth company. In 2025, Expion360 launched its e360 Home Energy Storage Solutions and reported significant revenue growth in the first two quarters of 2025, with 111% year-over-year growth in Q1 and 134% growth in Q2. The company completed a $2.6 million direct offering and private placement with institutional investors in early 2025 and has an At-The-Market Issuance Sales Agreement for up to $15 million in common stock sales. Leadership transitions occurred in 2025, with Joseph Hammer appointed CEO and Chairman, Shawna Bowin as CFO, and Carson Heagen as COO. The company reported full year 2025 revenue of approximately $9.65 million and a net loss of about $6.24 million, with liquidity ratios indicating strong short-term financial health as of December 31, 2025.